Surviving Surveillance-Are Current Head and Neck Cancer Posttreatment Surveillance Recommendations Better for Patients or Ourselves?

JAMA Otolaryngol Head Neck Surg. 2022 Jan 1;148(1):51-52. doi: 10.1001/jamaoto.2021.2892.

Authors

Andrew T Huang¹, Erich M Sturgis¹

Affiliation

¹ Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.

PMID: 34734978
DOI: 10.1001/jamaoto.2021.2892

No abstract available

Publication types

Comment

MeSH terms

Head and Neck Neoplasms* / therapy
Humans
Neoplasm Recurrence, Local